Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac versus nepafenac after cataract surgery
IRCT20220607055097N2Phase 4Completed
- Sponsor
- Nowshera Medical College
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of diclofenac and nepafenac in Postoperative ocular inflammation (2 arms), sponsored by Nowshera Medical College. Primary endpoints: Best corrected visual acuity, Central macular thickness and 1 more. Started Jan 2021; status: completed.
02
Drugs
diclofenacnepafenac
03
Conditions
Postoperative ocular inflammation
Beyond the preview
Go deeper on IRCT20220607055097N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220607055097N2.